Matches in Nanopublications for { ?s ?p "[We have used comparative genomic hybridization to identify genome copy number changes that can predict outcome in patients with stage IV neuroblastoma without MYCN amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP582743.RAa3Lf08AWpkMVdJ0hIcPxIQhsW5pMAY7uvTzleulnm4o130_assertion description "[We have used comparative genomic hybridization to identify genome copy number changes that can predict outcome in patients with stage IV neuroblastoma without MYCN amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582743.RAa3Lf08AWpkMVdJ0hIcPxIQhsW5pMAY7uvTzleulnm4o130_provenance.
- assertion description "[We have used comparative genomic hybridization to identify genome copy number changes that can predict outcome in patients with stage IV neuroblastoma without MYCN amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP691098.RAA0YPhUzGowmbyyYUxFfUpQ7tObQ6T_-b21LhY4rD-vM130_assertion description "[We have used comparative genomic hybridization to identify genome copy number changes that can predict outcome in patients with stage IV neuroblastoma without MYCN amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691098.RAA0YPhUzGowmbyyYUxFfUpQ7tObQ6T_-b21LhY4rD-vM130_provenance.
- NP691097.RAfDELFBXZTwNl-n1tkvWDh16EMRpybGepOeX5iWL3ykk130_assertion description "[We have used comparative genomic hybridization to identify genome copy number changes that can predict outcome in patients with stage IV neuroblastoma without MYCN amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691097.RAfDELFBXZTwNl-n1tkvWDh16EMRpybGepOeX5iWL3ykk130_provenance.
- NP582640.RAgC_Mmx3TrRVcVBhtsG2DjEUZyiezYA35QNCWWlz_F3g130_assertion description "[We have used comparative genomic hybridization to identify genome copy number changes that can predict outcome in patients with stage IV neuroblastoma without MYCN amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582640.RAgC_Mmx3TrRVcVBhtsG2DjEUZyiezYA35QNCWWlz_F3g130_provenance.